Atara Biotherapeutics (ATRA) EPS (Basic) (2013 - 2026)
Atara Biotherapeutics' (ATRA) quarterly EPS (Basic) came in at -$0.29 in Q1 2026, down 108.34% YoY from $3.53 in Q1 2025, and down 8.99% on a QoQ basis from -$0.27 in Q4 2025.
Atara Biotherapeutics (ATRA) EPS (Basic) (2013 - 2026) Analysis & Trends
Atara Biotherapeutics (ATRA) has 14 years of EPS (Basic) data on file, last reported at -$0.29 in Q1 2026.
- Quarterly EPS (Basic) fell 108.34% year-over-year to -$0.29 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.67 (up 53.82% YoY) and the FY2025 annual result came in at $2.61, up 122.86% from the prior year.
- EPS (Basic) slipped to -$0.29 in Q1 2026, from -$0.27 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $4.54 in Q2 2022 to a low of -$21.87 in Q1 2022.
- A 5-year average of -$7.78 and a median of -$3.1 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) plunged 472.29% — and 2025, when it soared 162.54%.
- Tracing ATRA's EPS (Basic) over 5 years: stood at -$18.28 in 2022, then grew by 21.94% to -$14.27 in 2023, then jumped by 88.12% to -$1.7 in 2024, then jumped by 84.07% to -$0.27 in 2025, then fell by 8.99% to -$0.29 in 2026.
- The last three EPS (Basic) figures came in at -$0.29 (Q1 2026), -$0.27 (Q4 2025), and -$0.32 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 0.18 |
| 10 | Atara Biotherapeutics | 143.49 Mn | 126.94 Mn | 439,000.00 | -0.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.34 |
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | 0.20 |
| Mar 31, 2025 | 3.53 |
| Dec 31, 2024 | -1.70 |
| Sep 30, 2024 | -2.93 |
| Jun 30, 2024 | -3.10 |
| Mar 31, 2024 | -5.65 |
| Dec 31, 2023 | -14.27 |
| Sep 30, 2023 | -16.40 |
| Jun 30, 2023 | -16.92 |
| Mar 31, 2023 | -17.98 |
| Dec 31, 2022 | -18.28 |
| Sep 30, 2022 | -20.53 |
| Jun 30, 2022 | 4.54 |
| Mar 31, 2022 | -21.87 |
| Dec 31, 2021 | -24.97 |
| Sep 30, 2021 | -22.61 |